Sonic Healthcare's Fiscal 2026 EBITDA Forecast to Be AU$1.9 Billion, Jefferies Says

MT Newswires Live

Jun 18

Sonic Healthcare (ASX:SHL) continues to expect earnings before interest, taxes, depreciation, and amortization (EBITDA) for fiscal year 2026 in the range of AU$1.87 billion to AU$1.95 billion at constant currency, compared with Jefferies' forecast of AU$1.9 billion, according to a Thursday note from Jefferies.

Sonic completed its previously flagged sale and leaseback of its Brisbane Hub Laboratory, and further property sale and leaseback transactions are under consideration.

The purchase price was AU$445 million, with rent, under a triple net lease arrangement, to begin at AU$25 million per annum. Sonic expects to book a fiscal year 2026 gain on sale before tax of around AU$100 million.

The investment firm retained its hold rating on Sonic and raised the price target to AU$22.60 per share from AU$22.55 per share.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2644775585"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2644775585\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2644775585?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-18 09:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2644775585","market":"sg","top_or_hot":-1,"title":"Sonic Healthcare's Fiscal 2026 EBITDA Forecast to Be AU$1.9 Billion, Jefferies Says","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/SKHCF\">Sonic Healthcare</a> (ASX:SHL) continues to expect earnings before interest, taxes, depreciation, and amortization (EBITDA) for fiscal year 2026 in the range of AU$1.87 billion to AU$1.95 billion at constant currency, compared with Jefferies' forecast of AU$1.9 billion, according to a Thursday note from Jefferies.</p><p>Sonic completed its previously flagged sale and leaseback of its Brisbane Hub Laboratory, and further property sale and leaseback transactions are under consideration.</p><p>The purchase price was AU$445  million, with rent, under a triple net lease arrangement, to begin at AU$25 million per annum. Sonic expects to book a fiscal year 2026 gain on sale before tax of around AU$100 million.</p><p>The investment firm retained its hold rating on Sonic and raised the price target to AU$22.60 per share from AU$22.55 per share.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sonic Healthcare's Fiscal 2026 EBITDA Forecast to Be AU$1.9 Billion, Jefferies Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSonic Healthcare's Fiscal 2026 EBITDA Forecast to Be AU$1.9 Billion, Jefferies Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-06-18 09:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/SKHCF\">Sonic Healthcare</a> (ASX:SHL) continues to expect earnings before interest, taxes, depreciation, and amortization (EBITDA) for fiscal year 2026 in the range of AU$1.87 billion to AU$1.95 billion at constant currency, compared with Jefferies' forecast of AU$1.9 billion, according to a Thursday note from Jefferies.</p><p>Sonic completed its previously flagged sale and leaseback of its Brisbane Hub Laboratory, and further property sale and leaseback transactions are under consideration.</p><p>The purchase price was AU$445  million, with rent, under a triple net lease arrangement, to begin at AU$25 million per annum. Sonic expects to book a fiscal year 2026 gain on sale before tax of around AU$100 million.</p><p>The investment firm retained its hold rating on Sonic and raised the price target to AU$22.60 per share from AU$22.55 per share.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4581","symbol_name":"高盛持仓","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2644775585","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2644775585","pubTimestamp":1781747202,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Sonic Healthcare  continues to expect earnings before interest, taxes, depreciation, and amortization  for fiscal year 2026 in the range of AU$1.87 billion to AU$1.95 billion at constant currency, compared with Jefferies' forecast of AU$1.9 billion, according to a Thursday note from Jefferies.Sonic completed its previously flagged sale and leaseback of its Brisbane Hub Laboratory, and further property sale and leaseback transactions are under consideration.The purchase price was AU$445  million, with rent, under a triple net lease arrangement, to begin at AU$25 million per annum. Sonic expects to book a fiscal year 2026 gain on sale before tax of around AU$100 million.The investment firm retained its hold rating on Sonic and raised the price target to AU$22.60 per share from AU$22.55 per share.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4581":"高盛持仓","BK7124":"保健护理服务","SHL.AU":"SONIC HEALTHCARE LTD","XLV":"健康照护类股ETF-SPDR","BK4585":"ETF&股票定投概念","BK4588":"碎股","XBI":"SPDR S&P Biotech ETF","LABU":"三倍做多标普生物-Direxion"},"translate_title":"杰富瑞表示，Sonic Healthcare 2026财年EBITDA预计为19亿澳元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LABU":0.6,"XLV":1.5,"XBI":0.6,"SHL.AU":1.5},"content_text":"Sonic Healthcare (ASX:SHL) continues to expect earnings before interest, taxes, depreciation, and amortization (EBITDA) for fiscal year 2026 in the range of AU$1.87 billion to AU$1.95 billion at constant currency, compared with Jefferies' forecast of AU$1.9 billion, according to a Thursday note from Jefferies.Sonic completed its previously flagged sale and leaseback of its Brisbane Hub Laboratory, and further property sale and leaseback transactions are under consideration.The purchase price was AU$445  million, with rent, under a triple net lease arrangement, to begin at AU$25 million per annum. Sonic expects to book a fiscal year 2026 gain on sale before tax of around AU$100 million.The investment firm retained its hold rating on Sonic and raised the price target to AU$22.60 per share from AU$22.55 per share.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}